Biotech News
Tango Therapeutics to Participate in Guggenheim’s 3rd Annual Healthcare Innovation Conference
BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX) today announced that Malte Peters, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at Guggenheim’s 3 rd Annual Healthcare Innovation Conference on
